- Abstract:
-
Current vaccine strategies against the asexual blood stage of Plasmodium falciparum are mostly focused on well-studied merozoite antigens that induce immune responses after natural exposure, but have yet to induce robust protection in any clinical trial. Here we compare human-compatible viral-vectored vaccines targeting ten different blood-stage antigens. We show that the full-length P. falciparum reticulocyte-binding protein homologue 5 (PfRH5) is highly susceptible to cross-strain neutraliz...
Expand abstract - Publication status:
- Published
- Journal:
- Nature communications
- Volume:
- 2
- Issue:
- 1
- Pages:
- 601
- Publication date:
- 2011
- DOI:
- EISSN:
-
2041-1723
- ISSN:
-
2041-1723
- URN:
-
uuid:f95d7a97-545e-401a-98b0-28689b3f78f6
- Source identifiers:
-
239835
- Local pid:
- pubs:239835
- Language:
- English
- Keywords:
- Copyright date:
- 2011
Journal article
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record